Explore life science companies operating throughout South East England, including biotechnology firms, CROs and research organisations.
Fermentation-derived food ingredients from agricultural waste streams
Fermtech is a biotechnology company that applies solid-state fungal fermentation to upcycle agricultural and brewing waste streams into food ingredients. Its lead product is produced from cocoa shells using Aspergillus oryzae fermentation and functions as a lower-cost, lower-carbon cocoa-enhancing ingredient for…
Precision fermentation and bio-based ingredients for food and feed
Mycofeast is an Oxford-headquartered industrial biotechnology company developing fermentation-derived ingredients for human and animal nutrition. It combines precision and biomass fermentation with microbial strain development and bioprocess scale-up to develop functional beverage ingredients, dairy proteins,…
Full-service clinical and commercial solutions across the drug development lifecycle
Syneos Health is a global biopharmaceutical solutions organisation providing integrated clinical and commercial services to pharmaceutical, biotechnology and medical device companies. Its Clinical Solutions offering spans Phase I to IV development, including clinical monitoring, patient recruitment, data management…
Specialist oncology CRO for early and late phase clinical trials
Theradex (Europe) Limited is the European arm of Theradex Oncology, a US-founded CRO with over 40 years specialising in oncology clinical development. The company provides full-service clinical trial management for pharma and biotech sponsors across early and late phase studies, with expertise in oncology,…
In vivo lentiviral CAR/TCR cell therapy platform for ovarian cancer
Akimbo Bio is an early-stage biotechnology company developing next-generation in vivo lentiviral vector technology for cell therapy. Its lead platform carries a dual CAR/TCR payload designed for direct in vivo delivery, with an initial focus on ovarian cancer. The technology uses intelligent receptor crosstalk, in…
Genomics platform developing RNA therapies for chronic liver disease
Ochre Bio is a biotechnology company developing RNA therapeutics for chronic liver disease using a platform built on large-scale human liver datasets. The platform integrates gene perturbation atlases, single-cell genomics from perfused donor livers, and machine learning to identify and validate disease-modifying drug…
Molecular and digital biomarkers for personalised cancer treatment
Oxford Cancer Biomarkers is a precision oncology diagnostics company developing molecular and digital pathology tests to support personalised cancer treatment. Its pharmacogenomic assays assess inherited variants associated with fluoropyrimidine chemotherapy toxicity, while its algorithm-driven pathology tools analyse…
Bispecific TCR therapies targeting HLA-Class II cancer antigens
Yellowstone Biosciences is a pre-clinical biotechnology company developing bispecific T-cell receptor therapies for oncology. The company targets a novel class of HLA Class II antigens expressed across multiple cancers, with an initial programme focused on acute myeloid leukaemia. Its approach is designed to…
Biological sensors that detect early crop stress signals
Viridys Bio is a synthetic biology company developing non-GMO biosensors that detect volatile organic compounds released by stressed plants. The sensors give a visual colour change alert before pest or disease symptoms become visible, allowing growers to intervene earlier and more precisely. Designed to require no…
Genetically engineered insects for sustainable pest and disease vector control
Flyttr is an Oxfordshire-based biotechnology company developing biological solutions for sustainable pest management. Its core technology uses genetically engineered insects carrying a self-limiting gene to suppress populations of disease-transmitting and crop-damaging pests without chemicals or harm to non-target…
Global drug discovery and development partnership company
Evotec is a global drug discovery and development company with major UK operations at Milton Park, Abingdon, and Alderley Park, Cheshire. Its Abingdon campus houses over 800 staff spanning target validation, medicinal chemistry, structural biology, in silico design, process development, and biologics manufacturing…
AI and quantum-chemical platform for small-molecule drug design
Tres Alchemix is the UK subsidiary of a Japanese biotechnology company developing an AI-driven drug-design platform for small-molecule therapeutics. The platform integrates quantum-level chemical calculations with AI models trained on biochemical and pharmacological datasets to predict the efficacy and safety of novel…
Therapeutic cancer vaccines based on recombinant overlapping peptide technology
Oxford Vacmedix is a clinical-stage biopharma company developing therapeutic cancer vaccines using its proprietary Recombinant Overlapping Peptide (ROP) platform. ROPs stimulate broad T cell and antibody immunity without HLA restriction, enabling a universal immunotherapy approach. The lead programme, OVM-200, targets…
Global bioprocess technology and life science tools provider
Cytiva is a global life sciences company providing technologies, instruments and services for biopharmaceutical research, development and manufacturing. Its UK operations span multiple sites including Amersham (protein analysis, Western blotting), Cardiff (single-use bioprocessing manufacturing, genomics R&D, magnetic…
World leading centre researching viral diseases of farm animals
The Pirbright Institute researches viral diseases of farm animals and viruses that spread from animals to humans. The Institute works to predict, detect and respond to livestock diseases, developing vaccines and diagnostic tests that support global food security and public health. Its high containment laboratories…
Global diabetes and cardiometabolic medicines leader
Novo Nordisk Limited is the UK commercial and medical affiliate of Novo Nordisk A/S, the Danish pharmaceutical company focused on diabetes, obesity, and cardiometabolic disease. The UK operation covers commercialisation, medical affairs, and clinical trial activities. Separately, Novo Nordisk Research Centre Oxford…
AI-driven skin microbiome platform for skincare and drug discovery
Biotix is a biotechnology company applying artificial intelligence and microbiome science to discover and develop novel approaches for skin health. Its AI platform analyses proprietary microbiome and clinical datasets to identify beneficial skin microbes and their metabolites, supporting both a commercial skincare…
Global biopharma focused on neurology and rare disease therapeutics
Biogen is a global biopharma company and one of the world's first biotechnology firms. The UK and Ireland headquarters in Maidenhead employs approximately 250 people across clinical operations, regulatory affairs, drug safety, and medical affairs. The company develops and commercialises therapies for neurological,…
Life sciences campus on former Pfizer R&D site in Kent
Discovery Park is a life sciences and enterprise campus occupying the former Pfizer global research and development site in Sandwich, Kent. The park provides laboratory, office, manufacturing and warehousing facilities to companies across drug discovery, diagnostics, therapeutics and immunology. It holds Enterprise…
Blood glycomic biomarkers for chronic inflammatory disease detection and monitoring
Avenna is a biotechnology company developing blood-based glycomic biomarkers for chronic inflammatory diseases. Its tests analyse the sugar structures attached to blood proteins to measure chronic inflammation separately from short-term acute inflammation, supporting early detection, disease monitoring and…